Janus Henderson Investors US’s Meridian Bioscience Inc VIVO Stock Holding History

Janus Henderson Investors US’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$142K	Hold	10,300	–	–	﹤0.01%	1146
2016 Q4	$182K	Hold	10,300	–	–	﹤0.01%	1189
2016 Q3	$199K	Hold	10,300	–	–	﹤0.01%	1210
2016 Q2	$201K	Hold	10,300	–	–	﹤0.01%	1172
2016 Q1	$212K	Sell	10,300 -3,900	-27%	-$76.8K	﹤0.01%	1143
2015 Q4	$291K	Sell	14,200 -4,100	-22%	-$78.6K	﹤0.01%	1138
2015 Q3	$313K	Buy	+18,300	New	+$334K	﹤0.01%	1123

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Janus Henderson Investors US's VIVO Position: Q1 2017 in Review

Janus Henderson Investors US held its Meridian Bioscience Inc (VIVO) position steady in Q1 2017 at 10,300 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #1146.

Janus Henderson Investors US first reported a position in VIVO in Q3 2015 and has held it in 7 quarters since. The position peaked at $313K in Q3 2015. 165 funds tracked by Wall St. Rank hold VIVO as of Q1 2017.

Janus Henderson Investors US held 10,300 shares of Meridian Bioscience Inc worth $142K as of Q1 2017.
Janus Henderson Investors US left its Meridian Bioscience Inc share count unchanged in Q1 2017.
Meridian Bioscience Inc made up ﹤0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #1146 holding.
Janus Henderson Investors US first reported a position in Meridian Bioscience Inc in Q3 2015 and has held it in 7 quarters since.
Janus Henderson Investors US's Meridian Bioscience Inc position peaked at $313K in Q3 2015.
165 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.